Did You Miss Acadia Healthcare Company's (NASDAQ:ACHC) Impressive 148% Share Price Gain?

By
Simply Wall St
Published
July 02, 2021
NasdaqGS:ACHC
Source: Shutterstock

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Acadia Healthcare Company, Inc. (NASDAQ:ACHC) share price has soared 148% in the last year. Most would be very happy with that, especially in just one year! It's also good to see the share price up 12% over the last quarter. But this move may well have been assisted by the reasonably buoyant market (up 6.4% in 90 days). And shareholders have also done well over the long term, with an increase of 50% in the last three years.

Check out our latest analysis for Acadia Healthcare Company

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Acadia Healthcare Company was able to grow EPS by 250% in the last twelve months. This EPS growth is significantly higher than the 148% increase in the share price. So it seems like the market has cooled on Acadia Healthcare Company, despite the growth. Interesting.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

earnings-per-share-growth
NasdaqGS:ACHC Earnings Per Share Growth July 2nd 2021

We know that Acadia Healthcare Company has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

A Different Perspective

It's nice to see that Acadia Healthcare Company shareholders have received a total shareholder return of 148% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 3% per year), it would seem that the stock's performance has improved in recent times. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 2 warning signs for Acadia Healthcare Company you should be aware of, and 1 of them is potentially serious.

Of course Acadia Healthcare Company may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you decide to trade Acadia Healthcare Company, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.


Simply Wall St character - Warren

Simply Wall St

Simply Wall St is focused on providing unbiased, high-quality research coverage on every listed company in the world. Our research team consists of data scientists and multiple equity analysts with over two decades worth of financial markets experience between them.